Cargando…

Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop

Detalles Bibliográficos
Autor principal: Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEGG. Published by Elsevier España, S.L.U. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981520/
https://www.ncbi.nlm.nih.gov/pubmed/36966078
http://dx.doi.org/10.1016/j.regg.2023.02.010
_version_ 1784900121561923584
author Finsterer, Josef
author_facet Finsterer, Josef
author_sort Finsterer, Josef
collection PubMed
description
format Online
Article
Text
id pubmed-9981520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SEGG. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-99815202023-03-03 Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop Finsterer, Josef Rev Esp Geriatr Gerontol Letter to the Editor SEGG. Published by Elsevier España, S.L.U. 2023 2023-03-03 /pmc/articles/PMC9981520/ /pubmed/36966078 http://dx.doi.org/10.1016/j.regg.2023.02.010 Text en © 2023 SEGG. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Finsterer, Josef
Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title_full Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title_fullStr Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title_full_unstemmed Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title_short Even after the fourth dose of a SARS-CoV-2 vaccine neurological complications may develop
title_sort even after the fourth dose of a sars-cov-2 vaccine neurological complications may develop
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981520/
https://www.ncbi.nlm.nih.gov/pubmed/36966078
http://dx.doi.org/10.1016/j.regg.2023.02.010
work_keys_str_mv AT finstererjosef evenafterthefourthdoseofasarscov2vaccineneurologicalcomplicationsmaydevelop